TN2010000368A1 - Treatment for ocular-related disorders - Google Patents

Treatment for ocular-related disorders

Info

Publication number
TN2010000368A1
TN2010000368A1 TNP2010000368A TN2010000368A TN2010000368A1 TN 2010000368 A1 TN2010000368 A1 TN 2010000368A1 TN P2010000368 A TNP2010000368 A TN P2010000368A TN 2010000368 A TN2010000368 A TN 2010000368A TN 2010000368 A1 TN2010000368 A1 TN 2010000368A1
Authority
TN
Tunisia
Prior art keywords
treatment
ocular
related disorders
macular degeneration
diabetic
Prior art date
Application number
TNP2010000368A
Other languages
French (fr)
Inventor
Thomas Oligino
Chang Hahn
Timothy A Gillespy
Ramalinga Dharanipragada
Ellen Matzkin
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2009/036119 external-priority patent/WO2009114373A1/en
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Publication of TN2010000368A1 publication Critical patent/TN2010000368A1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

A treatment for ocular related disorders, such as macular degeneration, and preferably age-related macular degeneration, diabetic retinopathy, and diabetic macular edema is disclosed, using a compound of Formula 1.
TNP2010000368A 2009-03-05 2010-08-10 Treatment for ocular-related disorders TN2010000368A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2009/036119 WO2009114373A1 (en) 2008-03-10 2009-03-05 Treatment for ocular-related disorders

Publications (1)

Publication Number Publication Date
TN2010000368A1 true TN2010000368A1 (en) 2011-12-29

Family

ID=55024497

Family Applications (1)

Application Number Title Priority Date Filing Date
TNP2010000368A TN2010000368A1 (en) 2009-03-05 2010-08-10 Treatment for ocular-related disorders

Country Status (1)

Country Link
TN (1) TN2010000368A1 (en)

Similar Documents

Publication Publication Date Title
MX347226B (en) Treatment of ocular disease.
MY175318A (en) Androgen composition for treating an opthalmic condition
TN2013000275A1 (en) Indole compounds or analogues thereof useful for the treatment of age-related macular degeneration (amd)
MY170713A (en) Treatment protocol of diabetes type 2
PH12014500281A1 (en) Compounds as tyrosine kinase modulators
GEP201706695B (en) Substituted 4-phenyl-pyridi-nes for the treatment of nk-1 receptor related diseases
WO2012080497A3 (en) Use of lp-pla2 inhibitors in the treatment and prevention of eye diseases
MX2014000781A (en) Fixed dose combination of bimatoprost and brimonidine.
WO2007098122A3 (en) Methods for the treatment of macular degeneration and related eye conditions
MX362271B (en) A crystalline form of cyclosporine a, methods of preparation, and methods for use thereof.
EA201490721A1 (en) Drug for the treatment of diseases of the anterior chamber of the eye, including rebamipid and tear-retaining agent
GEP20156315B (en) Oxazoline and isoxazoline derivatives as crac modulators
MY153738A (en) Sulphur-linked compounds for treating ophthalmic diseases and disorders.
NZ597866A (en) Therapeutic lactams
IN2012DN03846A (en)
WO2009109501A3 (en) Ocular pharmaceutical compositions
WO2007089673A8 (en) Compositions and methods for treatment of ophthalmic diseases and disorders
MX2010008308A (en) Treatment for ocular-related disorders.
MX2014003883A (en) Monoacylglycerol lipase inhibitors for the treatment of metabolic diseases and related disorders.
WO2008124151A3 (en) Use of creatine compounds for the treatment of eye disorders
WO2010046865A3 (en) Ophthalmic administration of a composition including brimonidine as a mist
TW200744627A (en) Methods for the treatment of macular degeneration and related eye conditions
TN2010000368A1 (en) Treatment for ocular-related disorders
MX2013006670A (en) 2-carboxamide-4-piperazinyl-benzofuran derivative.
GB201107576D0 (en) Novel compounds and methods for use in medicine